SEGLUROMET 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 2.5 mg/1 is used to improve glycemic control in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose through urine and reducing glucose production in the liver. This combination therapy is typically prescribed alongside diet and exercise for better management of blood sugar levels.

Common effects of Segluromet 2.5 mg/1 may include urinary tract infections, genital fungal infections, and gastrointestinal discomfort. Some users might experience symptoms like nausea, diarrhea, or low blood sugar, especially when starting the medication or adjusting doses.

Segluromet 2.5 mg/1 should be used with caution in individuals with kidney issues, as it can increase the risk of dehydration and urinary tract infections. It is important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before use if you have a history of metabolic acidosis or other serious medical conditions.

Segluromet 2.5 mg/1 may interact with certain medications, including diuretics, insulin, and other drugs that affect blood sugar levels. Alcohol can increase the risk of low blood sugar and should be avoided. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.